Hybrid coronary revascularization: the Emory experience

Abstract

This article reviews the Emory University Experience with hybrid coronary revascularization and identifies key factors essential for the success of this relatively new and evolving strategy for the treatment of coronary artery disease. Key decisional and technical factors were identified. In addition, careful patient selection, stepwise progression in learning the different aspects of the procedure, and close collaboration between cardiac surgery-interventional cardiology are key factors for success.

Keywords

Hybrid coronary revascularization / robotic coronary bypass / robotic LIMA LAD anastomosis

References

[1] Lytle BW,Sabik JF,Loop FD.The effect of bilateral internal thoracic artery grafting on survival during 20 postoperative years.Ann Thorac Surg2004;78:2005-12; discussion 2012-4

[2] Takagi H,Watanabe T,Kawai N.A meta-analysis of adjusted hazard ratios from 20 observational studies of bilateral versus single internal thoracic artery coronary artery bypass grafting.J Thorac Cardiovasc Surg2014;148:1282-90

[3] Voutilainen SM,Verkkala KA.Angiographic 20-year follow-up of 61 consecutive patients with internal thoracic artery grafts.Ann Surg1999;229:154-8 PMCID:PMC1191621

[4] Tatoulis J,Fuller JA.Patencies of 2,127 arterial to coronary conduits over 15 years.Ann Thorac Surg2004;77:93-101

[5] Serruys PW,Kappetein AP.SYNTAX InvestigatorsPercutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease.N Engl J Med2009;360:961-72

[6] Leon MB,Popma JJ.ENDEAVOR IV InvestigatorsA randomized comparison of the Endeavor zotarolimus-eluting stent versus the TAXUS paclitaxel-eluting stent in de novo native coronary lesions 12-month outcomes from the ENDEAVOR IV trial.J Am Coll Cardiol2010;55:543-54

[7] Dangas GD,Kereiakes DJ.Meta-analysis of everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease: final 3-year results of the SPIRIT clinical trials program (Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions).JACC Cardiovasc Interv2013;6:914-22

[8] Hess CN,Gibson CM.Saphenous vein graft failure after coronary artery bypass surgery: insights from PREVENT IV.Circulation2014;130:1445-51 PMCID:PMC4206593

[9] Fihn SD,Abrams J.American College of Cardiology Foundation/American Heart Association Task Force2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons.Circulation2012;126:e354-471

[10] Benetti FJ,Sani G,Grandjean J.Video assisted coronary bypass surgery.J Card Surg1995;10:620-5

[11] Vassiliades TA Jr,Puskas JD.Long-term results of the endoscopic atraumatic coronary artery bypass.Ann Thorac Surg2007;83:979-84; discussion 984-5

[12] Halkos ME,Myung RJ.Sternotomy versus nonsternotomy LIMA-LAD grafting for single-vessel disease.Ann Thorac Surg2012;94:1469-77

[13] Halkos ME,Vassiliades TA.Hybrid coronary revascularization versus off-pump coronary artery bypass for the treatment of left main coronary stenosis.Ann Thorac Surg2011;92:2155-60

[14] Halkos ME,Douglas JS.Hybrid coronary revascularization versus off-pump coronary artery bypass grafting for the treatment of multivessel coronary artery disease.Ann Thorac Surg2011;92:1695-701; discussion 1701-2

[15] Halkos ME,Devireddy C.Early clinical and angiographic outcomes after robotic-assisted coronary artery bypass surgery.J Thorac Cardiovasc Surg2014;147:179-85

[16] Kayatta MO,Puskas JD.Hybrid coronary revascularization for the treatment of multivessel coronary artery disease.Ann Cardiothorac Surg2018;7:500-5 PMCID:PMC6082776

[17] Zhou S,Xiong H.Effect of one-stop hybrid coronary revascularization on postoperative renal function and bleeding: a comparison study with off-pump coronary artery bypass grafting surgery.J Thorac Cardiovasc Surg2014;147:1511-6.e1

[18] Harskamp RE,Alexander JH.Clinical outcomes of hybrid coronary revascularization versus coronary artery bypass surgery in patients with diabetes mellitus.Am Heart J2014;168:471-8

[19] Harskamp RE,Halkos ME.Clinical outcomes after hybrid coronary revascularization versus coronary artery bypass surgery: a meta-analysis of 1,190 patients.Am Heart J2014;167:585-92

[20] Harskamp RE,Xian Y.Practice patterns and clinical outcomes after hybrid coronary revascularization in the United States: an analysis from the society of thoracic surgeons adult cardiac database.Circulation2014;130:872-9

[21] Harskamp RE,Mehta RH.Comparative effectiveness of hybrid coronary revascularization vs coronary artery bypass grafting.J Am Coll Surg2015;221:326-34.e1

[22] Rosenblum JM,Hoedemaker N.Hybrid coronary revascularization versus coronary artery bypass surgery with bilateral or single internal mammary artery grafts.J Thorac Cardiovasc Surg2016;151:1081-9

[23] Généreux P,Palmerini T.Stent Thrombosis and dual antiplatelet therapy interruption with everolimus-eluting stents: insights from the Xience V Coronary Stent System Trials.Circ Cardiovasc Interv2015;8:e001362